Xeltis has reported positive preliminary data for its Xabg coronary artery bypass conduit (CABG) in a trial that is underway at EU sites.

Saluda Medical has announced the full US commercial launch of its EVA sensing technology intended for scanning and analysing the spinal cord.

Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Viome, with Scripps Research, is set to develop and clinically validate the first RNA test for detecting precancerous colon polyps.

The medical device industry faces being pulled into a broader contest over control, sovereignty and industrial self-sufficiency.

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

The US FDA has cleared Intuitive's Vessel Sealer Curved for use with the company’s multiport da Vinci surgical systems.

Researchers at the University of Queensland (UQ) have developed a new device to facilitate drug delivery into the brain safely.